A Randomized Phase 2 Study of Gefitinib With or Without Pemetrexed as First-line Treatment in Nonsquamous NSCLC With EGFR Mutation: Final Overall Survival and Biomarker Analysis.

Details

Language :

English

ISSN :

15560864

Volume :

15

Issue :

1

Database :

Complementary Index

Journal :

Journal of Thoracic Oncology

Publication Type :

Academic Journal

Accession number :

145439772

Full Text :

https://doi.org/10.1016/j.jtho.2019.09.008